MedPath

A clinical trial to study the efficacy of the drug misoprostol administered rectally in reducing excessive bleeding after normal delivery

Not Applicable
Conditions
Health Condition 1: null- Women with singleton pregnancy undergoing normal vaginal delivery
Registration Number
CTRI/2014/08/004910
Lead Sponsor
DrSMCSIMedical college
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
320
Inclusion Criteria

women with singleton pregnancy

cephalic presentation

>28 weeks of gestational age

Hb >10gms

Exclusion Criteria

patients undergoing cesarean section and instrumental delivery

malpresentation

multiple pregnancy

past history of post partum haemorrhage

coagulopathies

heart disease/renal disease

placenta previa/abruptio placenta

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
fall in haemoglobin and PCV levelsTimepoint: 24 hours
Secondary Outcome Measures
NameTimeMethod
Duration of third stage of labour <br/ ><br>Timepoint: 1 hour
© Copyright 2025. All Rights Reserved by MedPath